Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cashflow Statement

INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹-75 Cr₹124 Cr₹193 Cr₹237 Cr₹132 Cr
Adjustment ₹184 Cr₹138 Cr₹121 Cr₹87 Cr₹110 Cr
Changes In working Capital ₹2.78 Cr₹-88 Cr₹-73 Cr₹-109 Cr₹-140 Cr
Cash Flow after changes in Working Capital ₹111 Cr₹173 Cr₹240 Cr₹215 Cr₹102 Cr
Cash Flow from Operating Activities ₹95 Cr₹155 Cr₹179 Cr₹174 Cr₹82 Cr
Cash Flow from Investing Activities ₹-339 Cr₹-433 Cr₹-208 Cr₹-121 Cr₹-67 Cr
Cash Flow from Financing Activities ₹241 Cr₹280 Cr₹23 Cr₹-44 Cr₹-30 Cr
Net Cash Inflow / Outflow ₹-2.76 Cr₹3.31 Cr₹-6.54 Cr₹8.05 Cr₹-14 Cr
Opening Cash & Cash Equivalents ₹15 Cr₹11 Cr₹17 Cr₹9.42 Cr₹24 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -₹0.62 Cr---
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹12 Cr₹15 Cr₹11 Cr₹17 Cr₹9.42 Cr

Compare Cashflow Statement of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,532.3 Cr -1.3% -11.7% -23.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,594.0 Cr -3.3% -6.9% -9.7% Stock Analytics
DIVIS LABORATORIES ₹162,722.0 Cr 1.7% -6.8% 25.4% Stock Analytics
CIPLA ₹127,508.0 Cr -0.9% 0.5% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,111.0 Cr -1.9% -1.3% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,225.0 Cr -1.2% -2% -9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-1.3%

-11.7%

-23.1%

SENSEX

-2.2%

-1.7%

-1.2%


You may also like the below Video Courses